Upcoming Event - The Pharmaceutical Strategy Series' Third Annual Drug Development China
6/4/2008
Event:
The Pharmaceutical Strategy Series’ Third Annual Drug Development China: Strategies for Launching Discovery and Development Activities
Date(s): September 16-18, 2008
Organizer: Cambridge Healthtech Institute
Venue: The Fairmont, San Francisco, CA
Tel: +1 781-972-5400
Weblink:
www.healthtech.com/pcc/overview.aspx
The Pharmaceutical Strategy Series’ Third Annual Drug Development China conference will be of interest to those seeking to take advantage of the recent regulatory improvements, skilled labor, patient population and quality research of the region - and overcoming the obstacles and leveraging the incredible opportunities offered by China. This executive forum features incredible learning and networking opportunities from US / Chinese biopharmaceutical and biotech's.
Three Days of Interactive Discussions, Case Studies, Break-out Roundtables, and Panels:
- In-Licensing, Out-licensing and Risk Sharing: The China Landscape for Partnership Deals
- Interactions and Initiatives Taken for Drug Development between China and the Rest of Asia: A Focus on Oncology
- Opportunities for Drug Discovery in China: Chemistry, Biology, Integrated Projects & Traditional Chinese Medicine
- How to Conduct High Quality, Cost-Effective GLP Safety Studies in China
- Strategic Planning for Clinical Development Operations in China
- Comparative Assessment of Regulatory Processes and Time Lines
- The Role of Academic Clinical Trials Units for Drug Development in Asia
- Business Model Case Studies: Real Challenges and Strategies to Harness R&D Capabilities in China
Pre-Conference Workshop:
Improving China Drug Development Team Performance: Essential Partnering Strategies, Skills and Processes, Tuesday, September 16
This event is organized by The Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute. If you would like to register by telephone or have questions, call CHI at 781-972-5400.